Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Cortex Pharmaceuticals (AMEX:COR)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Msgs | Insider
Location
15241 Barranca Parkway
Irvine, CA 92618
Phone: (949) 727-3157
Fax: (949) 727-3657
Email: ir@cortexpharm.com
Employees (last reported count): 23
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 2%
·Over the last 6 months:
 · 5 insider buys; 54.0K shares (19.7% of insider shares)
·Institutional: 0% (0% of float)
(8 institutions)
·Net Inst. Buying: 10.0K shares (+33.38%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Cortex Pharmaceuticals, Inc. is engaged in the discovery, development and commercialization of pharmaceuticals for the treatment of neurodegenerative diseases and other neurological and psychiatric disorders. The primary effort of Cortex is centered on developing products that affect the AMPA-type glutamate receptor, a complex of proteins that is involved in most "excitatory" communication between nerve cells in the human brain. Cortex is developing a family of chemical compounds, known as Ampakines, which enhance the activity of this receptor. Cortex believes that Ampakines hold promise for correcting deficits brought on by a variety of diseases and disorders that are known, or thought, to involve depressed functioning of pathways in the brain that use glutamate as a neurotransmitter.
More from Market Guide: Expanded Business Description

Financial Summary
COR is a development stage company engaged in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders. For the nine months ended 3/31/01, revenues rose 4% to $2.8 million. Net loss rose 41% to $1.9 million. Revenues reflect the collaboration agreement with Servier. Earnings were offset by increased research/development expenses and stock based compensation expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Robert Allnutt, 65
Chairman
--  --  
Vincent Simmon, Ph.D., 57
Pres, CEO, Director
$295K$113K
Maria Messinger, 33
CFO, VP, Sec., Controller
131K--  
James Coleman
Sr. VP, Bus. Devel.
166K--  
Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- AMEX:CORAs of 31-Aug-2001
Price and Volume
52-Week Low
on 29-Dec-2000
$1.406
Recent Price$2.08 
52-Week High
on 7-Sep-2000
$4.50 
Beta0.91 
Daily Volume (3-month avg)19.0K
Daily Volume (10-day avg)24.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-30.7%
52-Week Change
relative to S&P500
-7.0%
Share-Related Items
Market Capitalization$34.6M
Shares Outstanding16.6M
Float16.3M
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 5 on 12-Jan-1995
Per-Share Data
Book Value (mrq)$0.04 
Earnings (ttm)-$0.04 
Earnings (mrq)-$0.01 
Sales (ttm)$0.34 
Cash (mrq)$0.29 
Valuation Ratios
Price/Book (mrq)45.99 
Price/EarningsN/A 
Price/Sales (ttm)6.13 
Income Statements
Sales (ttm)$5.62M
EBITDA (ttm)-$837.0K
Income available to common (ttm)-$762.0K
Profitability
Profit Margin (ttm)-13.5%
Operating Margin (ttm)-17.6%
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter31-Mar-2001
Management Effectiveness
Return on Assets (ttm)-18.19%
Return on Equity (ttm)-64.59%
Financial Strength
Current Ratio (mrq)2.27 
Debt/Equity (mrq)0 
Total Cash (mrq)$4.88M
Short Interest
As of 8-Aug-2001
Shares Short0 
Shares Short
(Prior Month)
0 
Daily Volume18.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.